1. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: final policy recommendations Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 17, 2021 Subject(s): Antibodies, MonoclonalDermatitis, AtopicJanus Kinase InhibitorsUnited States
